Providence Capital Advisors’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-127
| Closed | -$2.26K | – | 374 |
|
|
2024
Q2 | $2.26K | Hold |
127
| – | – | ﹤0.01% | 306 |
|
|
2024
Q1 | $1.93K | Hold |
127
| – | – | ﹤0.01% | 298 |
|
|
2023
Q4 | $2.17K | Hold |
127
| – | – | ﹤0.01% | 301 |
|
|
2023
Q3 | $1.06K | Hold |
127
| – | – | ﹤0.01% | 326 |
|
|
2023
Q2 | $3.16K | Hold |
127
| – | – | ﹤0.01% | 260 |
|
|
2023
Q1 | $1.91K | Hold |
127
| – | – | ﹤0.01% | 274 |
|
|
2022
Q4 | $1.5K | Buy |
+127
| New | +$1.5K | ﹤0.01% | 257 |
|